Literature DB >> 4342317

Dysfibrinogenaemia associated with primary hepatoma.

R Verhaeghe, B van Damme, A Molla, J Vermylen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4342317     DOI: 10.1111/j.1600-0609.1972.tb00968.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


× No keyword cloud information.
  6 in total

1.  Dysfibrinogenemia associated with liver disease.

Authors:  J E Palascak; J Martinez
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Sensitive and rapid measurement of fibrin polymerisation by laser nephelometry.

Authors:  A Ruiz-Arguelles; B Perez-Romano
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

3.  Dysfibrinogenaemia and liver cell growth.

Authors:  R D Barr; M Allardyce; P W Brunt; J L McPhie
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

4.  Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.

Authors:  J Martinez; J E Palascak; D Kwasniak
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).

Authors:  S Matsuzaki; K Iwamura; M Itakura; T Katsunuma
Journal:  Gastroenterol Jpn       Date:  1980

6.  Acquired dysfibrinogenaemia in liver disease.

Authors:  J L Francis; D J Armstrong
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.